Alessandro Riva
CIK 1867172 · last filed 2026-06-15
Alessandro Riva is a corporate insider who has filed 16 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for ONC, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$65.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.2M across reported positions. 9 SEC filings were submitted jointly with BeiGene, Ltd.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ONC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3675 MARKET STREET
PHILADELPHIA, PA 19104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONC | Director | 73,164 | $370.87 | $27.13M | -$65.6K | 3 | 2026-06-15 |
| IPSC | Director | — | $1.42 | — | $0 | 6 | 2026-06-12 |
| BCYC | Director | 19,880 | $3.65 | $72.6K | $0 | 2 | 2026-01-06 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 45,955 | $184.71 | $8.49M | $0 | 4 | 2024-06-07 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | ONC | Grant (A) | +18,980 | $0 | EDGAR |
| 2026-06-12 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2026-05-27 | ONC | Sell (S) | −212 | -$65.6K | EDGAR |
| 2026-05-22 | — | Notice (144) | −212 | -$65.6K | EDGAR |
| 2026-01-06 | BCYC | Grant (A) | +7,380 | $0 | EDGAR |
| 2025-06-16 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | ONC | Grant (A) | +10,985 | $0 | EDGAR |
| 2025-03-27 | BCYC | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-06-21 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +16,341 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.